Lovelace Biomedical


Lovelace Biomedical is a not-for-profit preclinical contract research organization dedicated to advancing biomedical science through nonclinical and clinical research focused on toxicology, drug development, infectious diseases, and more. With a history spanning nearly seven decades, it emphasizes personalized service, scientific excellence, and innovative technologies. The organization has played a significant role in responding to COVID-19 by developing therapeutics and animal models to fight the virus. It is committed to humane animal care, environmental enrichment, and supporting research that improves health and well-being.

Industries

biotechnology
non-profit
pharmaceutical

Nr. of Employees

large (251-1000)

Lovelace Biomedical

Albuquerque, New Mexico, United States, North America


Products

Gene Therapy Services

Comprehensive contract research organization (CRO) services for gene therapy nonclinical development, including safety, efficacy, and biodistribution studies, regulatory support, and IND-enabling packages.

Gene Therapy Toxicology & Preclinical Research Services

General and specialized toxicology studies conducted under Good Laboratory Practice (GLP) or non-GLP guidelines, covering small molecules, biologics, gene therapies, and cell therapies.

Preclinical GLP Toxicology Studies

Comprehensive GLP toxicology research and contract research services supporting pharmaceutical, biotech, and chemical companies in safety assessments and regulatory submissions.

Preclinical Pharmacology Research

Preclinical pharmacology research services utilizing more than 100 animal models of disease in large and small animals to evaluate safety and efficacy.

Respiratory Drug Development Services

Comprehensive contract research services supporting pharmaceutical and biotechnology companies in the discovery, evaluation, and nonclinical development of novel respiratory therapies.

Full-Service Contract Research Laboratory for Preclinical Development

Comprehensive preclinical contract research services supporting the advancement of innovative drug candidates from discovery to clinical trials, including toxicology, pharmacokinetics, and bioanalytical support.

View All Products

Services

Method development, method validation, sample analysis, metabolite identification, biomarker analysis and PK/TK support across multiple analytical platforms.

Design and conduct of GLP toxicology and pharmacology studies, including IND/NDA-enabling programs and safety assessments in multiple species.

Aerosol exposure testing, inhaler and nebulizer characterization, regional deposition studies and inhalation delivery development for pulmonary and systemic therapeutics.

Efficacy, biodistribution, immunogenicity and toxicology studies tailored to gene therapy products, with support for pre‑IND interactions and regulatory submissions.

Multi-species animal housing, surgical suites, colony management and logistical support for long-term and large-scale preclinical programs.

Onsite microbiology and virology laboratory testing integrated with high-containment studies to support infectious disease research and medical countermeasure evaluation.

View All Services

Expertise Areas

  • Preclinical GLP toxicology
  • Bioanalytical chemistry and regulated method validation
  • Pharmacokinetics / toxicokinetics and PK/PD modeling
  • Inhalation and aerosol drug-delivery development
  • Show More (10)

Key Technologies

  • Liquid chromatography–tandem mass spectrometry (LC-MS/MS)
  • Immunoassays (ELISA, electrochemiluminescence)
  • qPCR / RT‑PCR
  • Flow cytometry
  • Show More (9)

News & Updates

Research on RSV and therapeutics development.

Research on aerosol science and mask performance related to COVID-19.

Discussion on the use of animals in non-clinical research.

Recognition for high impact research in aerosol science and mask performance.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.